Susanna Palkonen is Director of European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), which brings together 42 member associations from 25 countries to improve the care, environment, participation and equality of people with allergy, asthma and COPD at the European level. Among others, Susanna is the patient representative in the EC DG Research and Innovation’s Horizon 2020 Scientific Panel for Health, ERACoSysMed Advisory Board, eTriks IMI Project Ethics and Safety Board and the Advisory Board of the Human Brain Project.
She just stepped down from the Board of the European Patients’ Forum EPF, the umbrella association for 64 European level disease specific patient groups and national platforms of patient associations, after 12 years of service and where she was vice president 8 years and represented EPF at the European Medicines Agency (EMA) Patient and Consumer Working Party. In her private life she recently became the Secretary of the Board of the Lehmijärvi-lake protection association, lake in Finland where her family has summer cottage, with the aim to improve the quality of the water for anyone wishing to swim in or fish on the lake. Susanna has co-authored several papers with the scientific community and believes in equal participation in research by patients and their representatives. She studied social policy and as a patient with atopic eczema and allergic rhinitis she is interested in how policies and systems, but also patients themselves can support patient centered care and prevention.
Jan De Belie is a Belgian pharmacist working as the Professional Affairs Advisor at the Pharmaceutical Group of the European Union (PGEU), the European Association representing community pharmacists in 32 European countries. Before joining PGEU, Jan worked at the Association of Belgian Pharmacists (APB) whilst also working part-time as a community pharmacist in practice.
In his role, Jan is responsible for the PGEU activities concerning professional related issues and liaising with PGEU members and stakeholders on these topics. Other specific responsibilities are to further develop the relationship of PGEU with EMA, with other pharmacy and health professional associations and with parts of the Commission dealing with Pharmaceuticals.
After having gained his diploma on the job, Ber trained as a general nurse in 1980 and specialized in mental health nursing in the long-term high-care clinical setting. Currently he is unit leader on a ward for patients with severe mental conditions in Nijmegen Netherlands.
In 2003 he joined the Dutch association for psychiatric nursing as secretary and was co-founder of the European Association for Psychiatric Nurses in Europe. He fulfilled the role as secretary general in the organisation until 2009. In 2005 he took part in the first network meeting of the European Specialist Nurses Organisations and in 20008 accepted the position of secretary. He reformed the network into an European association based in Brussels and is the current executive secretary of the ESNO.
In his position he is responsible for the overall management of the association, being proactive in expanding the network of specialist nurses, advocating their role and recognition under the EU directive of professional qualification. He is active in a variety of health programs: Expert group health workforce of DG Sante, member of European Policy Platform, Expert EMA Health Professional Working Party, participant in focus group in OECD on skills mismatches, active in the future Joined Actions on Vaccination, Anti-Microbial Resistance and Health Workforce. He is project leader on the Nurses Information and Communication Guide on Biosimilars.
In addition he is also a strong promoter of Continuing Professional Development and Life Long Learning during the nursing career lifespan and has a personal passion for creative thinking, generating opportunities and interconnecting chances for others and loves outdoors activities in nature.
Internal Medicine Harbor Hospital, Institute for Tropical Diseases, Rotterdam, the Netherlands, Member of the European Scientific Working Group on Influenza (ESWI)
Sally Kendall is Professor of Community Nursing and Public Health at the University of Kent and the Chair of the European Forum for Primary Care.
She became a health visitor and family planning nurse in 1982 and worked in SW London until taking up a research post at Kings College London and completing her PhD on the health visitor-client interaction. She was a lecturer in nursing from 1988 to 1996 in Buckinghamshire and had two children during that time.
She was previously Professor of Nursing and Director of the Centre for Research in Primary and Community Care, University of Hertfordshire from 2000-2016.
Her main research interest is in community health, especially in client/patient experience and in family and child public health research, having developed the TOPSE tool for measuring parenting self-efficacy. This has led to her research with Aboriginal communities in Western Australia.
She also currently leads the NIHR/HEE Mentorship Programme for Academic Clinical Careers.
She is the co-editor of Primary Health Care Research and Development and the co-chair of the International Collaboration of Community Health Nursing Research, a UK charity that supports global community nursing research and a founding trustee of the Institute of Health Visiting.
Roberta Savli is a public affairs professional with more than five years’ experience in EU health, environment and research policies. Before joining European Federation of Allergy and Airways Diseases Patients’ Associations, Roberta has worked at the European Commission and the European Parliament. She holds a double masters degree in International Relations from LUISS University in Rome and in European Studies from the College of Europe.
As Director of Strategy and Policy, she is in charge of EFA’s Human Resources and leads EFA’s Membership and Policy teams, maintaining the relations with their network of members and being responsible for EFA’s advocacy activities. She is a Young Gasteiner and she also represents EFA at the Patients’ and Consumers’ Working Party of the European Medicines Agency, the Executive Committee of Health and Environment Alliance and the Policy Advisory Group of the European Patients’ Forum. She chairs EFA’s Food Allergy Working Group.
Dr Tainijoki-Seyer manages a variety of strategic projects at WMA ranging from infectious and non-communicable diseases to strengthening health systems, patient safety, access to quality-assured medicines and the social determinants of health. Dr Tainijoki-Seyer serves as the WMA representative to the UN organizations, including WHO and other international institutions in Geneva, Switzerland. For over 10 years she also headed the secretariat of the World Health Professions Alliance (WHPA) representing more than 26 million healthcare professionals globally, was management board member of the Global Social Observatory for 8 years and editorial board member of Southern Medical Journal. Dr Tainijoki-Seyer is a family physician, trained in Germany, UK and Switzerland with a Master’s in International Health Economy and Policy from the University of Bocconi in Milan, Italy.
Jamie Wilkinson commenced his role as Pharmaceuticals and Professional Affairs Adviser of the PGEU in January 2014 before becoming Director of Professional Affairs in April 2015.
The Pharmaceutical Group of the European Union (PGEU) is the European Association representing community pharmacists in 32 European countries.
A pharmacist by training, he has experience in the community pharmacy sector and academia in the UK, in addition to experience in health policy, professional affairs and advocacy.
He holds an MPharm, Master of Pharmacy from the Universities of Kingston & St George’s, an MSc in Social Research Methods from the University of Sussex and an MPH, Master of Public Health from the University of Sheffield. He is a Member of the Royal Pharmaceutical Society UK, a Fellow of the Royal Society for Public Health UK and a Practitioner Member of the Faculty of Public Health UK.
Emilie Karafillakis is a research fellow at the Vaccine Confidence Project, at the London School of Hygiene & Tropical Medicine. She has a background in public health, infectious diseases control and health systems research. Emilie is a qualitative researcher working on vaccine hesitancy and confidence amongst European populations, including parents, adolescents and healthcare workers. Her current research focuses on understanding determinants of vaccine hesitancy in Europe and strategies addressing concerns about vaccination, including communication and behavioural interventions.
Prof. Esposito is a Full Professor of Pediatrics at the School of Medicine and Director of the Specialty School of Pediatrics at the University of Perugia. She is President of the World Association for Infectious Diseases and Immunological Disorders (WAidid) since 2014, Chair of the Vaccine Study Group of the European Society for Clinical Microbiology and Infectious Diseases since 2013, a member of the Steering Committee on Vaccination of the Italian Society of Pediatrics since 2016 and was President of the Italian Society of Pediatric Infectious diseases from 2011-2015. She has won several postgraduate awards; and has been International Editor of The Paediatric Infectious Disease Journal (since 2005), Associate Editor of BMC Infectious Diseases (since 2009), Associate Editor of Human Vaccines & Immunotherapeutics (since 2010), Associate Editor of Journal of Clinical Virology (since 2012) and Editorial Board Member of PLOS One (since 2013). Prof. Esposito’s research has focused on respiratory tract infections, vaccines and preventive paediatrics, anti-infective therapy and emerging infections. Her research activities have led to the publication of more than 300 articles in international journals reported by PubMed with an impact factor of over3,000.
Previously he was Chief Medical Officer and Chief Operating Officer of Hirslanden Holding, the largest private hospital chain in Switzerland. As an academic, he held appointments at the universities of Munich, Bayreuth, Milano and Zurich. In 2010 he received an honorary professorship of the University of Peking.
He has worked at F. Hoffman-La Roche, as the global head of Health Economics and served as Chairman of BB Biotech, Bioxell SpA, Intercell AG and was founding Chairman of Okairos. Currently he is Vice Chairman of Biovertis AG and since 2010 Chairman of the largest Swiss healthcare insurer, Helsana Group.
He holds a medical degree from the University of Basel, a Masters in Business Administration from the University of St Gallen, a Master of Public Health degree from Harvard University and an LL.M in International Business Law from the University of Zurich.
Thomas is board certified in Pharmaceutical Medicine as well as in Prevention and Public Health. He has published more than 400 articles, book chapters and monographies. He has worked extensively in the field of pharmaceutical economics and epidemiology. Recently he started a small practice in personalised medicine with special emphasis on pharmacogenomics at the Klinik Hirslanden in Zurich.
Member of the European Parliament since 1994, Françoise Grossetête is a law graduate from the University of Lyon. She started her career as a university teacher before being elected at local level, first as deputy Mayor of Saint-Etienne (1983-2008) and then as President of the Pilat Natural Park (1989-2008). In the European Parliament, she is Vice-President of the European People’s Party Group since 2014, a position she held already before, between 1999 and 2007. François Grossetête sits in the committees for the Environment, Public Health and Food Safety, and Research, Industry and Energy. With a strong focus on health policies, she has carried through Parliament a number of legislations related to pharmaceuticals and healthcare. A former Regional counsellor for Rhône-Alpes, she is also member of the Political Bureau of Les Républicains.